Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Experimental Cell Research|May 1, 2025
The dynamic interplay between melanoma cells and CAFs: Implications drug resistance and immune evasion and possible therapeuticsChou-Yi Hsu, Raed Obaid Saleh, Jaafaru Sani Mohammed, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 28, 2025
Melanoma and its fibroblastic allies: the emerging importance of CAFs in immune suppression, ECM modulation, and therapy resistanceChou-Yi Hsu, Raed Obaid Saleh, Jaafaru Sani Mohammed, et al.
Frontiers in Pharmacology|December 12, 2025
CXCR4-targeted therapy in lung cancer: plerixafor as a promising antimetastatic agentPrasanna Srinivasan Ramalingam, Muhammad Afzal, M Arockia Babu, et al.
Iranian Journal of Basic Medical Sciences|September 2, 2025
CRISPR/Cas9 in colorectal cancer: Revolutionizing precision oncology through genome editing and targeted therapeuticsBahjat Alhasso, Abdulkareem Shareef, Lalji Baldaniya, et al.
Journal of Ethnicity in Substance Abuse|May 21, 2025
Cannabis use in different ethnicity/race populations and risk of ischemic stroke: A systematic review and meta-analysisFarah Thamer Abdullah, Abdulla A Al-Dulaimi, Krunal Vaghela, et al.
Medical Oncology (Northwood, London, England)|December 26, 2025
Exosomal non-coding RNAs as emerging drivers of immune dysregulation in melanomaBahaa Ibrahim Saeed, Wesam R Kadhum, Muhammad Ikram Ullah, et al.
Reproductive Biology|June 10, 2026
NLRs and preeclampsia: Advances in etiology, pathogenesis, and therapeutic targeting, highlighting NLRP3Chou-Yi Hsu, Saade Abdalkareem Jasim, Nisreen Salah Majeed, et al.
Scientific Reports|August 7, 2025
Evaluation of different sedation scales in the ICU management of COVID-19 patientsSarah F Al-Taie, Muzdalifa Mejbel Fedwi, Mohammed Merza, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 8, 2025
Galectin-3 as a cardiac biomarkerAsif Ahmad Bhat, Yahia Alghazwani, Kumarappan Chidambaram, et al.
Frontiers in Immunology|December 8, 2025
Targeting cancer via macrophage-derived exosomal miRNAs: implications for tumor progression and resistancePrasanna Srinivasan Ramalingam, Muhammad Afzal, M Arockia Babu, et al.
Pageof 9